ProKidney Corp. is a late clinical-stage biotechnology company focused on pioneering cell therapy as a treatment for Chronic Kidney Disease (CKD). Their innovative approach aims to transform the therapeutic options available for advanced CKD by preserving kidney function, potentially delaying or eliminating the need for dialysis. With a focus on an area of high unmet medical need, ProKidney's cell therapy candidate, rilparencel, is at the forefront of clinical studies to provide alternative solutions for patients with limited treatment options. The company is committed to advancing its pipeline through clinical and regulatory developments and actively participates in healthcare conferences to bring attention to its groundbreaking work in CKD treatment.
5 days ago
Director of Patient Advocacy at ProKidney focuses on CKD treatment and community engagement initiatives.
November 23, 2024
IT Manager oversees technology implementation for bioanalytical systems, enhancing CKD treatment. Join groundbreaking work transforming kidney therapy.